Malaria Minute
Mosquito Saliva Vaccine Evaluated in Phase 1 Trial
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:01:00
- Mas informaciones
Informações:
Sinopsis
The Latest Malaria News, in 60 Seconds. Researchers evaluate the immunogenicity of the AGS-v vaccine which targets saliva produced by Anopheles gambiae mosquitoes. More: www.fightmalaria.uk/MalariaMinute
